Kidney Transplant after Clearing Anti-HLA Antibodies with CD19 Car T Cells
Apollo (University of Cambridge) · 04.06.2026
DOI: 10.17863/cam.130902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apollo (University of Cambridge), erschienen am 04.06.2026. Verfasst von Brian J.P. Huntly.
Abstract (Originalsprache)
HLA sensitization remains a major barrier to kidney transplantation.1,2 Transplantation in the presence of donor-specific HLA antibodies confers a high risk of antibody-mediated rejection (AMR), often necessitating intensified immunosuppression and resulting in premature graft loss. We report the clinical course of a broadly HLA-sensitized patient in whom anti-CD19 CAR T cell therapy enabled successful kidney transplantation.
Schlagwörter
Zitieren
APA
Huntly, B. J. (2026). Kidney Transplant after Clearing Anti-HLA Antibodies with CD19 Car T Cells. Apollo (University of Cambridge). https://doi.org/10.17863/cam.130902
Vancouver
Huntly BJ. Kidney Transplant after Clearing Anti-HLA Antibodies with CD19 Car T Cells. Apollo (University of Cambridge). 2026. doi:10.17863/cam.130902
BibTeX
@article{Huntly2026,
author = {Huntly, Brian J.P.},
title = {Kidney Transplant after Clearing Anti-HLA Antibodies with CD19 Car T Cells},
journal = {Apollo (University of Cambridge)},
year = {2026},
doi = {10.17863/cam.130902}
}
EUVIMED